Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis-Reference-Cited by-同舟云学术

Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis

Published:2014-07 Issue:7 Volume:8 Page:571-581
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Thorlund Kristian,Druyts Eric,Mills Edward J.,Fedorak Richard N.,Marshall John K.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/8/7/571/1510616/8-7-571.pdf

Reference35 articles.

1. Inflammatory bowel disease: clinical aspects and established and evolving therapies;Baumgart;Lancet,2007

2. Colorectal cancer risk and mortality in patients with ulcerative colitis;Langholz;Gastroenterology,1992

3. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase;Masuda;J Clin Lab Immunol,1995

4. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis;Nielsen;Am J Gastroenterol,1999

5. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis;Ishiguro;J Gastroenterol,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis;Cureus;2024-06-02

2. Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD;Journal of Immunology Research;2023-06-20

3. Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn’s Disease;Biomolecules;2023-06-07

4. Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria® (golimumab);International Journal of Pharmaceutics;2023-03

5. Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis;eClinicalMedicine;2023-03